10.8 0 (0%) | 04-24 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 12.72 | 1-year : | 12.8 |
Resists | First : | 10.89 | Second : | 10.96 |
Pivot price | 10.8 | |||
Supports | First : | 10.78 | Second : | 8.97 |
MAs | MA(5) : | 10.8 | MA(20) : | 10.8 |
MA(100) : | 10.85 | MA(250) : | 10.62 | |
MACD | MACD : | -0.1 | Signal : | -0.1 |
%K %D | K(14,3) : | 7.8 | D(3) : | 8.1 |
RSI | RSI(14): 46 | |||
52-week | High : | 12.19 | Low : | 10 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ IVCP ] has closed above bottom band by 30.7%. Bollinger Bands are 90.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 10.84 - 10.89 | 10.89 - 10.93 |
Low: | 10.65 - 10.72 | 10.72 - 10.78 |
Close: | 10.7 - 10.81 | 10.81 - 10.9 |
Swiftmerge Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in West Vancouver, Canada.
Wed, 14 Feb 2024
Swiftmerge's Merger Agreement Termination and Implications - TipRanks.com - TipRanks
Mon, 14 Aug 2023
HDL Therapeutics eyes public listing in $480m SPAC deal - pharmaphorum
Fri, 11 Aug 2023
HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp. - Business Wire
Mon, 24 Apr 2023
HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge ... - Business Wire
Sat, 19 Mar 2022
10 Stocks to Buy According to Himanshu Gulati's Antara Capital - Insider Monkey
Wed, 23 Feb 2022
BRLI to merge with penny stock crypto exchange Nukkleus; VIEW learns about not filing the hard way - TheStreet
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Financial Services
|
|
Industry:
Shell Companies
|
|
Shares Out | 5 (M) |
Shares Float | 1 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 42.2 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0.21 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | -0.38 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | -1.6 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | -29.7 % |
Operating Cash Flow | -1 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 49.09 |
PEG Ratio | 0 |
Price to Book value | -29.19 |
Price to Sales | 0 |
Price to Cash Flow | -54.27 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |